Determination of Inosine Monophosphate Dehydrogenase Activity in Human CD4+ Cells Isolated from Whole Blood During Mycophenolic Acid Therapy
Authors:
- Stein BerganSBStein Bergan
- 1 October 2006
- journal article
- Published by Wolters Kluwer Health in Therapeutic Drug Monitoring
- Vol. 28 (5) , 608-613
Abstract
Inosine 5′-monophosphate dehydrogenase (IMPDH) is an established target in immunosuppression following organ transplantation. In lymphocytes, reversible inhibition of this enzyme by mycophenolic acid (MPA) results in reduced production of guanine and deoxyguanine nucleotides and thereby retarded proliferation of activated cells. In order to examine MPA pharmacodynamics in renal allograft recipients, the authors have developed an assay for the determination of IMPDH activity in CD4+ cells directly isolated from a small blood volume. Paramagnetic beads coated with anti-CD4 antibodies were utilized for the cell isolation. The intracellular MPA concentration was restored by incubating the cells in microfiltrated plasma from the original sample. Inosine 5′-monophosphate (IMP; substrate) and nicotine adenine dinucleotide (NAD; co-factor) were added to cell lysates, and IMPDH activity was quantified as the xanthosine 5′-monophosphate (XMP) production rate (pmol/106 cells/min) determined by liquid chromatography after hydrolytic cleavage to xanthine. The reaction kinetics were saturated with IMP and NAD concentrations of 1.79 μmol/L and 0.38 μmol/L, respectively. The production rate was linear in the interval 0.13 to 8.7 pmol XMP/min. Total interseries CVs based on seven replicates at each MPA concentration 0, 2.2, and 8.6 μg/mL were 25%, 16%, and 13%, respectively. When a single 1 gram mycophenolate mofetil dose was administered to a healthy individual, the measured IMPDH activity was 13% of predose value at the MPA peak concentration. The present assay allows reliable determination of IMPDH activity in CD4+ cells during MPA exposure, reducing the potential influence of sample preparation on the measured enzyme activity to a minimum. The assay may be applied to assess MPA pharmacodynamics during immunosuppressive treatment, maintaining the influence of intracellular MPA on the IMPDH activity.Keywords
This publication has 16 references indexed in Scilit:
- Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Pharmacokinetics in Renal Transplant Recipients at Different Postgrafting PeriodsTherapeutic Drug Monitoring, 2005
- Early Adequate Mycophenolic Acid Exposure is Associated with Less Rejection in Kidney TransplantationAmerican Journal of Transplantation, 2004
- Mycophenolate mofetil and its mechanisms of actionImmunopharmacology, 2000
- A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1Transplantation, 1999
- Inosine-5′-Monophosphate Dehydrogenase: Regulation of Expression and Role in Cellular Proliferation and T Lymphocyte Activation1998
- MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1997
- Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytesBiochemical Journal, 1992
- Direct assay method for inosine 5′-monophosphate dehydrogenase activityAnalytical Biochemistry, 1985
- A straightforward radiometric technique for measuring IMP dehydrogenaseAnalytical Biochemistry, 1983
- The inhibition of nucleic acid synthesis by mycophenolic acidBiochemical Journal, 1969